Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Healthwise HoldingsHKSE:00348 -6.12% EV-to-FCF is 7.91 as of Aug. 12, 2026. The stock has 3 warning signs investors should review. Among 407 Healthcare Providers & Services companies, China Healthwise Holdings ranks better than 81.08% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, China Healthwise Holdings's Enterprise Value is HK$119.01 Mil.
China Healthwise Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$15.05 Mil. Therefore, China Healthwise Holdings's EV-to-FCF for today is 7.91.
The historical rank and industry rank for China Healthwise Holdings's EV-to-FCF or its related term are showing as below:
HKSE:00348'
s EV-to-FCF Range Over the Past 10 Years
Min: -51.28 Med: -0.16 Max: 206.08
Current: 7.65
During the past 13 years, the highest EV-to-FCF of China Healthwise Holdings was 206.08. The lowest was -51.28. And the median was -0.16.
HKSE:00348's EV-to-FCF is ranked better than 81.08% of 407
companies
in the Healthcare Providers & Services industry
Industry Median: 18.75
vs HKSE:00348: 7.65
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Healthwise Holdings (HKSE:00348) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China Healthwise Holdings's PE Ratio (TTM) for today is calculated as:
China Healthwise Holdings's share price for today is HK$0.092.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Healthwise Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.003.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
China Healthwise Holdings EV-to-FCF Related Terms
China Healthwise Holdings EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings EV-to-FCF Competitor Comparison
For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Healthwise Holdings EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where China Healthwise Holdings's EV-to-FCF falls into.
China Healthwise Holdings's current Enterprise Value is HK$119.01 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Healthwise Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$15.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Healthwise Holdings (HKSE:00348) has a EV-to-FCF of 7.91 as of Aug. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Healthwise Holdings and its competitors. According to the industry distribution chart, China Healthwise Holdings ranks #77 out of 407 companies in the Healthcare Providers & Services industry, placing it in the top 18.9%.
Is China Healthwise Holdings' EV-to-FCF too high?
China Healthwise Holdings' current EV-to-FCF is 7.91. The Healthcare Providers & Services industry median EV-to-FCF is 18.75. China Healthwise Holdings' value of 7.91 is 57.8% below this industry median. Based on the distribution chart, China Healthwise Holdings ranks #77 out of 407 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does China Healthwise Holdings' EV-to-FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, China Healthwise Holdings ranks #77 out of 407 companies for EV-to-FCF. This places China Healthwise Holdings in the top 19% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 18.75. China Healthwise Holdings' value of 7.91 is 57.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.75, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Healthwise Holdings's current EV-to-FCF of 7.91 is 57.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China Healthwise Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Healthwise Holdings's current EV-to-FCF is 7.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Healthwise Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Healthwise Holdings (HKSE:00348) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.09 — trading 53.3% above its estimated fair value. The current EV-to-FCF is 7.91 and 57.8% below the Healthcare Providers & Services industry median of 18.75. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For China Healthwise Holdings (HKSE:00348), the current EV-to-FCF is 7.91 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which includes, pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00348 has been successfully added to your 
